Brokerages predict that athenahealth, Inc (NASDAQ:ATHN) will post $0.92 earnings per share for the current quarter, Zacks Investment Research reports. Twenty Two analysts have made estimates for athenahealth’s earnings. The highest EPS estimate is $1.11 and the lowest is $0.82. athenahealth reported earnings of $0.51 per share during the same quarter last year, which suggests a positive year-over-year growth rate of 80.4%. The business is expected to report its next earnings results on Thursday, July 19th.
According to Zacks, analysts expect that athenahealth will report full-year earnings of $4.01 per share for the current financial year, with EPS estimates ranging from $3.67 to $4.56. For the next fiscal year, analysts anticipate that the business will report earnings of $4.63 per share, with EPS estimates ranging from $4.10 to $5.68. Zacks Investment Research’s earnings per share calculations are an average based on a survey of research analysts that that provide coverage for athenahealth.
athenahealth (NASDAQ:ATHN) last issued its earnings results on Thursday, April 26th. The health services provider reported $1.25 earnings per share for the quarter, beating the Zacks’ consensus estimate of $0.72 by $0.53. The firm had revenue of $329.40 million for the quarter, compared to the consensus estimate of $318.13 million. athenahealth had a return on equity of 13.01% and a net margin of 6.77%. The company’s revenue was up 15.4% compared to the same quarter last year. During the same quarter last year, the business posted $0.32 EPS.
A number of equities research analysts have weighed in on ATHN shares. ValuEngine downgraded athenahealth from a “hold” rating to a “sell” rating in a report on Friday, April 27th. Oppenheimer raised their target price on athenahealth from $158.00 to $179.00 and gave the company an “outperform” rating in a report on Tuesday, June 19th. Citigroup cut their price objective on athenahealth from $148.00 to $140.00 and set a “neutral” rating on the stock in a report on Monday, April 30th. Royal Bank of Canada set a $136.00 price objective on athenahealth and gave the company a “hold” rating in a report on Monday, April 30th. Finally, Robert W. Baird raised their price objective on athenahealth to $150.00 and gave the company an “outperform” rating in a report on Tuesday, May 8th. Seventeen research analysts have rated the stock with a hold rating and nine have assigned a buy rating to the company’s stock. The stock currently has an average rating of “Hold” and a consensus price target of $154.81.
In other athenahealth news, insider Daniel P. Haley sold 1,107 shares of athenahealth stock in a transaction dated Wednesday, May 16th. The stock was sold at an average price of $149.40, for a total transaction of $165,385.80. Following the transaction, the insider now directly owns 12,383 shares of the company’s stock, valued at approximately $1,850,020.20. The sale was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this link. Also, CEO Jonathan Bush sold 5,000 shares of athenahealth stock in a transaction dated Tuesday, May 1st. The stock was sold at an average price of $124.01, for a total value of $620,050.00. Following the transaction, the chief executive officer now directly owns 340,106 shares in the company, valued at $42,176,545.06. The disclosure for this sale can be found here. Insiders have sold a total of 36,979 shares of company stock worth $5,544,854 over the last ninety days. Company insiders own 2.90% of the company’s stock.
Several hedge funds have recently bought and sold shares of ATHN. Millennium Management LLC raised its position in shares of athenahealth by 146.2% in the 1st quarter. Millennium Management LLC now owns 201,736 shares of the health services provider’s stock worth $28,854,000 after acquiring an additional 119,784 shares in the last quarter. ArrowMark Colorado Holdings LLC raised its position in shares of athenahealth by 30.1% in the 4th quarter. ArrowMark Colorado Holdings LLC now owns 511,863 shares of the health services provider’s stock worth $68,098,000 after acquiring an additional 118,411 shares in the last quarter. Summit Trail Advisors LLC raised its position in shares of athenahealth by 13,481.3% in the 1st quarter. Summit Trail Advisors LLC now owns 103,218 shares of the health services provider’s stock worth $103,000 after acquiring an additional 102,458 shares in the last quarter. Natixis bought a new position in shares of athenahealth in the 1st quarter worth about $14,590,000. Finally, Victory Capital Management Inc. bought a new position in shares of athenahealth in the 1st quarter worth about $12,511,000.
Shares of ATHN stock traded down $0.25 during trading hours on Friday, reaching $159.18. The company’s stock had a trading volume of 598 shares, compared to its average volume of 266,757. The company has a market cap of $6.39 billion, a PE ratio of 101.64, a P/E/G ratio of 2.96 and a beta of 1.26. athenahealth has a fifty-two week low of $111.61 and a fifty-two week high of $163.94. The company has a debt-to-equity ratio of 0.25, a quick ratio of 2.71 and a current ratio of 2.71.
athenahealth Company Profile
athenahealth, Inc, together with its subsidiaries, provides network-based medical record, revenue cycle, patient engagement, care coordination, and population health services for medical groups and health systems. It offers athenaCollector, a network-enabled billing and practice management solution; athenaClinicals, an electronic health record for managing patient's clinical documentation; athenaCommunicator, an engagement and communication solution that provides an automated communication service between patients and provider practices for interactions outside the exam room; and athenaCoordinator for order transmission and care coordination services.
Get a free copy of the Zacks research report on athenahealth (ATHN)
For more information about research offerings from Zacks Investment Research, visit Zacks.com
Receive News & Ratings for athenahealth Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for athenahealth and related companies with MarketBeat.com's FREE daily email newsletter.